Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica N McAlpine

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Nature Methods|May 17, 2016
Clonal genotype and population structure inference from single-cell tumor sequencingAndrew Roth, Andrew McPherson, Emma Laks, et al.
Gynecologic Oncology|June 13, 2008
Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapyJoshua Z Press, Jennifer A Kenyon, Hui Xue, et al.
Journal of Biomedical Optics|December 22, 2016
Fluorescence confocal endomicroscopy of the cervix: pilot study on the potential and limitations for clinical implementationColin Schlosser, Nico Bodenschatz, Sylvia Lam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patternsEmily F Thompson, Julia Chen, Jutta Huvila, et al.
American Journal of Obstetrics and Gynecology|January 14, 2014
Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer preventionJessica N McAlpine, Gillian E Hanley, Michelle M M Woo, et al.
BMC Cancer|December 17, 2009
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapyJessica N McAlpine, Kimberly C Wiegand, Russell Vang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 13, 2022
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinomaEmily F Thompson, Kathryn Shum, Richard W C Wong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
British Journal of Cancer|July 28, 2018
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profileFelix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 8, 2026
Complications Following Bilateral Salpingectomy by Indication: Population-Based Cohort StudyAlexandra Lukey, Helena Abreu do Valle, A Fuchsia Howard, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Nature Methods|May 17, 2016
Clonal genotype and population structure inference from single-cell tumor sequencingAndrew Roth, Andrew McPherson, Emma Laks, et al.
Gynecologic Oncology|June 13, 2008
Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapyJoshua Z Press, Jennifer A Kenyon, Hui Xue, et al.
Journal of Biomedical Optics|December 22, 2016
Fluorescence confocal endomicroscopy of the cervix: pilot study on the potential and limitations for clinical implementationColin Schlosser, Nico Bodenschatz, Sylvia Lam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patternsEmily F Thompson, Julia Chen, Jutta Huvila, et al.
American Journal of Obstetrics and Gynecology|January 14, 2014
Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer preventionJessica N McAlpine, Gillian E Hanley, Michelle M M Woo, et al.
BMC Cancer|December 17, 2009
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapyJessica N McAlpine, Kimberly C Wiegand, Russell Vang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 13, 2022
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinomaEmily F Thompson, Kathryn Shum, Richard W C Wong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
British Journal of Cancer|July 28, 2018
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profileFelix Kf Kommoss, Anthony N Karnezis, Friedrich Kommoss, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 8, 2026
Complications Following Bilateral Salpingectomy by Indication: Population-Based Cohort StudyAlexandra Lukey, Helena Abreu do Valle, A Fuchsia Howard, et al.
Pageof 19